secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2026-09-15T20:06:36+00:00
Accession:  0001193125-26-391903
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics raises ~$2.5M via private placement of pre-funded and common warrants
--------------------------------------------------------------------------------

- Issued pre-funded warrants for 3,105,591 shares at $0.001 exercise price, plus Series C/D warrants for same count.
- Combined price $0.804 per unit; gross proceeds ~$2.5M, up to ~$5M more if common warrants exercised.
- Series C warrants ($0.805 strike, 6yr) and Series D (3yr) exercisable after stockholder approval; 90 days to seek approval.
- H.C. Wainwright placement agent; 7% cash fee and warrants for 217,391 shares at $1.0063.
- Proceeds for working capital; 30-day lock-up on new issuance, 60-day ban on variable-rate deals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526391903/0001193125-26-391903-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526391903/d108044d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-391903

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer